Research Progress of Estrogen Receptor in Ovarian Cancer

被引：3
|
作者：
Zhang, Mengchen [1 ,2 ]
Xu, Haohui [1 ,2 ]
Zhang, Yixin [1 ,2 ]
Li, Zhanfei [1 ,2 ]
Meng, Wenqiang [1 ,2 ]
Xia, Jiayi [1 ,2 ]
Lei, Wentao [1 ,2 ]
Meng, Kai [1 ,3 ]
Guo, Yan [4 ]
机构：
[1] Jining Med Univ, Collaborat Innovat Ctr Birth Defect Res & Transfor, Jining 272067, Shandong, Peoples R China
[2] Jining Med Univ, Coll Clin Med 2, Jining 272067, Shandong, Peoples R China
[3] Jining Med Univ, Lin Hes Academician Workstn New Med & Clin Transla, Jining 272067, Shandong, Peoples R China
[4] Jining Med Univ, Coll Basic Med, Jining 272067, Shandong, Peoples R China
来源：
CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY | 2023年 / 50卷 / 09期
关键词：
ovarian cancer; estrogen; estrogen receptor; receptor modulators; precise treatment; ER-ALPHA; POOR-PROGNOSIS; BETA; OVEREXPRESSION; CARCINOMA; TRANSCRIPTION; EXPRESSION; TAMOXIFEN; GROWTH; PROLIFERATION;
D O I：
10.31083/j.ceog5009199
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Objective: This review aims to provide some theoretical guidance for the precise treatment of ovarian cancer and the development of estrogen-related drugs. Mechanism: Ovarian cancer is one of the leading causes of death in gynecological cancer patients, mainly affecting middle-aged and elderly women. It has the characteristics of hidden location, strong heterogeneity and lack of specific symptoms in the early stage. Numerous studies have shown that estrogen receptor (ER) plays an important role in different types of cancer, including ovarian cancer. Accordingly, the study of ER signaling pathways and related regulatory factors in ovarian cancer cells should help us understand the pathogenesis of ovarian cancer. Findings in Brief: The expression of estrogen receptor subtypes is related to ovarian cancer gene and leads to ovarian cancer. Estrogen receptor modulators appear to be an important factor in the prognosis of patients with ovarian cancer after hormone therapy. Conclusions: This review summarizes the regulatory mechanism of ER in the occurrence and development of ovarian cancer and outlines the specific role of estrogen receptor modulators (SERMs) in the treatment and prevention of ovarian cancer.
引用
收藏
页数：10
相关论文
共 50 条
  • [31] Clinical Response to Antiestrogen Therapy in Platinum-Resistant Ovarian Cancer Patients and the Role of Tumor Estrogen Receptor Expression Status
    Stasenko, Marina
    Plegue, Melissa
    Sciallis, Andrew P.
    McLean, Karen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (02) : 222 - 228
  • [32] Potent genistein derivatives as inhibitors of estrogen receptor alpha-positive breast cancer
    Marik, Radharani
    Allu, Madhan
    Anchoori, Ravi
    Stearns, Vered
    Umbricht, Christopher B.
    Khan, Saeed
    CANCER BIOLOGY & THERAPY, 2011, 11 (10) : 883 - 892
  • [33] Up-regulation of cyclin E in breast cancer via estrogen receptor pathway
    Niu, Dehong
    Wang, Gang
    Wang, Xiuwen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (01): : 910 - 915
  • [34] Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
    Liu, Jinyou
    Viswanadhapalli, Suryavathi
    Garcia, Lauren
    Zhou, Mei
    Nair, Binoj C.
    Kost, Edward
    Tekmal, Rajeshwar Rao
    Li, Rong
    Rao, Manjeet K.
    Curiel, Tyler
    Vadlamudi, Ratna K.
    Sareddy, Gangadhara R.
    ONCOTARGET, 2017, 8 (30) : 50002 - 50014
  • [35] MiR-206 inhibits estrogen signaling and ovarian cancer cell migration without affecting GPER
    Boscaro, Carlotta
    Ramaschi, Giovanni Eugenio
    Trevisi, Lucia
    Cignarella, Andrea
    Bolego, Chiara
    LIFE SCIENCES, 2023, 333
  • [36] Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence
    Reid, Steven E.
    Pantaleo, Jessica
    Bolivar, Paulina
    Bocci, Matteo
    Sjolund, Jonas
    Morsing, Mikkel
    Cordero, Eugenia
    Larsson, Sara
    Malmberg, Maria
    Seashore-Ludlow, Brinton
    Pietras, Kristian
    ONCOGENE, 2024, 43 (15) : 1113 - 1126
  • [37] Expression of estrogen-related receptors in ovarian cancer and impact on survival
    Schueler-Toprak, Susanne
    Weber, Florian
    Skrzypczak, Maciej
    Ortmann, Olaf
    Treeck, Oliver
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2555 - 2567
  • [38] Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer
    Mungenast, Felicitas
    Aust, Stefanie
    Vergote, Ignace
    Vanderstichele, Adriaan
    Sehouli, Jalid
    Braicu, Elena
    Mahner, Sven
    Castillo-Tong, Dan Cacsire
    Zeillinger, Robert
    Thalhammer, Theresia
    ONCOLOGY LETTERS, 2017, 13 (06) : 4047 - 4054
  • [39] Research progress in intratumoral heterogeneity and clinical significance of ovarian cancer
    Pu, Tengda
    Zhang, Chengyuan
    Su, Bingfeng
    Li, Li
    Fu, Jingjing
    MEDICINE, 2024, 103 (04)
  • [40] Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: From the 'MALOVA' Ovarian Cancer Study
    Hogdall, Estrid V. S.
    Christensen, Lise
    Hogdall, Claus K.
    Blaakaer, Jan
    Gayther, Simon
    Jacobs, Ian J.
    Christensen, Ib Jarle
    Kjaer, Susanne K.
    ONCOLOGY REPORTS, 2007, 18 (05) : 1051 - 1059
12345